Group One Trading
AGIO icon

Group One Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Group One Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Sell
90,700
-56,700
-38% -$1.61M 0.01% 1690
2025
Q4 		$4.01M Buy
147,400
+114,500
+348% +$4.02M 0.01% 1697
2025
Q3 		$1.32M Buy
32,900
+21,700
+194% +$816K ﹤0.01% 2735
2025
Q2 		$373K Sell
11,200
-3,300
-23% -$100K ﹤0.01% 3717
2025
Q1 		$425K Sell
14,500
-7,600
-34% -$252K ﹤0.01% 3264
2024
Q4 		$726K Buy
22,100
+15,600
+240% +$733K ﹤0.01% 2870
2024
Q3 		$289K Buy
6,500
+1,000
+18% +$45.4K ﹤0.01% 3298
2024
Q2 		$237K Buy
5,500
+2,500
+83% +$90.2K ﹤0.01% 3253
2024
Q1 		$87.7K Hold
3,000
– – ﹤0.01% 4257
2023
Q4 		$66.8K Sell
3,000
-63,500
-95% -$1.42M ﹤0.01% 4822
2023
Q3 		$1.65M Buy
66,500
+12,900
+24% +$341K 0.01% 1810
2023
Q2 		$1.52M Buy
53,600
+38,000
+244% +$946K ﹤0.01% 1971
2023
Q1 		$358K Sell
15,600
-36,400
-70% -$967K ﹤0.01% 3088
2022
Q4 		$1.46M Sell
52,000
-14,300
-22% -$403K ﹤0.01% 2099
2022
Q3 		$1.88M Sell
66,300
-35,100
-35% -$942K ﹤0.01% 1982
2022
Q2 		$2.25M Buy
101,400
+11,200
+12% +$253K ﹤0.01% 1953
2022
Q1 		$2.63M Buy
90,200
+5,200
+6% +$159K ﹤0.01% 2121
2021
Q4 		$2.79M Buy
85,000
+75,900
+834% +$3.06M ﹤0.01% 2246
2021
Q3 		$420K Sell
9,100
-7,600
-46% -$367K ﹤0.01% 4393
2021
Q2 		$920K Buy
16,700
+14,200
+568% +$794K ﹤0.01% 3516
2021
Q1 		$129K Sell
2,500
-21,600
-90% -$1.07M ﹤0.01% 5420
2020
Q4 		$1.04M Buy
24,100
+9,700
+67% +$384K ﹤0.01% 2603
2020
Q3 		$504K Sell
14,400
-5,600
-28% -$245K ﹤0.01% 2834
2020
Q2 		$1.07M Sell
20,000
-103,000
-84% -$4.77M ﹤0.01% 1958
2020
Q1 		$4.36M Buy
123,000
+53,700
+77% +$2.48M 0.04% 606
2019
Q4 		$3.31M Buy
69,300
+48,000
+225% +$1.81M 0.02% 926
2019
Q3 		$690K Buy
21,300
+21,100
+10,550% +$873K 0.01% 2068
2019
Q2 		$10K Sell
200
-10,200
-98% -$545K ﹤0.01% 4407
2019
Q1 		$701K Sell
10,400
-100
-1% -$5.83K 0.01% 1681
2018
Q4 		$484K Sell
10,500
-8,900
-46% -$549K ﹤0.01% 2007
2018
Q3 		$1.5M Sell
19,400
-43,700
-69% -$3.52M 0.01% 1380
2018
Q2 		$5.32M Sell
63,100
-2,400
-4% -$209K 0.05% 509
2018
Q1 		$5.36M Sell
65,500
-1,400
-2% -$108K 0.05% 435
2017
Q4 		$3.83M Buy
66,900
+8,700
+15% +$547K 0.03% 787
2017
Q3 		$3.88M Sell
58,200
-2,700
-4% -$162K 0.04% 631
2017
Q2 		$3.13M Buy
60,900
+6,700
+12% +$343K 0.03% 693
2017
Q1 		$3.17M Buy
54,200
+2,000
+4% +$95.9K 0.04% 608
2016
Q4 		$2.18M Buy
52,200
+13,600
+35% +$714K 0.02% 874
2016
Q3 		$2.04M Buy
38,600
+27,500
+248% +$1.2M 0.02% 840
2016
Q2 		$465K Sell
11,100
-8,700
-44% -$430K 0.01% 1782
2016
Q1 		$804K Buy
19,800
+17,700
+843% +$757K 0.01% 1335
2015
Q4 		$136K Sell
2,100
-2,400
-53% -$157K ﹤0.01% 2787
2015
Q3 		$318K Sell
4,500
-900
-17% -$88K ﹤0.01% 2150
2015
Q2 		$600K Buy
5,400
+1,100
+26% +$118K 0.01% 1615
2015
Q1 		$405K Sell
4,300
-1,100
-20% -$123K 0.01% 1781
2014
Q4 		$605K Sell
5,400
-3,500
-39% -$312K 0.01% 1412
2014
Q3 		$546K Buy
8,900
+8,600
+2,867% +$371K 0.01% 1550
2014
Q2 		$14K Buy
+300
New +$12.2K ﹤0.01% 4358

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Group One Trading's AGIO Position: Q1 2026 in Review

Group One Trading increased its Agios Pharmaceuticals (AGIO) stake by 4% in Q1 2026, buying an estimated $189K and bringing the position to 173,279 shares worth $5.86M. The position accounts for 0.01% of the portfolio, ranked #1175.

Group One Trading first reported a position in AGIO in Q4 2014 and has held it in 34 quarters since. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Group One Trading held 173,279 shares of Agios Pharmaceuticals worth $5.86M as of Q1 2026.
  • Group One Trading bought 6,665 Agios Pharmaceuticals shares in Q1 2026, an estimated $189K.
  • Agios Pharmaceuticals made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1175 holding.
  • Group One Trading first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 34 quarters since.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.